in a 4-week study of etodolac ( 600 and 1000 mg/day ) and piroxicam ( 20 mg/day ) given to patients with osteoarthritis or rheumatoid arthritis , blood loss seen with etodolac was comparable to that seen with placebo and significantly less than that seen with piroxicam .
C0031990
piroxicam
C0003873
rheumatoid